BioSpace News Archive

Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces announces that CEO Dr. Faz Chowdhury will present a corporate overview at the 13th Annual LD Micro Main Event virtual investor conference on Tuesday, December 15 at 8:00 AM PST/11:00 AM EST.

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its inclusion in two CME sessions, at the Fall Clinical Dermatology Virtual Grand Rounds (the “FCVGR”) and the 23rd Annual Mount Sinai Winter Symposium “Advances in Medical and Surgical Dermatology” (the “Mount Sinai Symposium”).

Perimeter Medical Imaging AI, Inc. announced today that Jeremy Sobotta, Perimeter’s Chief Executive Officer, will present a corporate overview at the 13th Annual LD Micro Main Event (virtual) investor conference on Monday, December 14, 2020 at 12:40 pm ET.

Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that its President and Chief Scientific Officer, Jude Samulski, PhD, has been honored as Triangle Business Journal’s (TBJ) 2020 Business Person of the Year. “My passion to help people is reflected in the work we do every day to bring much-needed treatments to patients and their families who ar

Agendia, Inc., a world leader in precision oncology for breast cancer, today announced that additional data from its groundbreaking MINDACT study will be highlighted in an oral presentation by Laura van ’t Veer, Ph.D., Co-founder and Chief Research Officer, at the 2020 San Antonio Breast Cancer Symposium (SABCS 2020).

AGS Health, a leader in revenue cycle management services for major healthcare providers across the U.S. today announced it has been recognized by KLAS ® Research as a “consistent high performer” in their report, “Outsourced Codin

The Allen Institute for Cell Science, a division of the Allen Institute, announced today that Ruwanthi (Ru) Gunawardane, Ph.D., has been named Executive Director, effective January 9, 2021 , providing executive direction and leadership. Susanne Rafelski, Ph.D., Deputy Director, will manage and lead the scientific research. Rick

MTX110 Programmes to be Presented at The International Symposium on Pediatric Neuro-Oncology, Karuizawa, Japan (ISPNO 2020)

Representatives of patient advocacy groups, expert physicians, thought leaders, and representatives from the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research came together on December 9 at a roundtable sponsored by the Plasma Protein Therapeutics Association (PPTA) to discuss the impacts on people with rare diseases if not enough plasma is available to manufacture lifesaving plasma-derived therapies

Adamas Pharmaceuticals, Inc. announced that the compensation committee of the company’s board of directors granted two new employees the option to purchase an aggregate of 28,500 shares of the company’s common stock, at a per share exercise price of $4.88, the closing trading price on December 7, and restricted stock units to acquire 14,250 shares of the company’s common stock.